2025
SJR Q2
JCR Q3 · 2,8
OA
3 matched articles
SCIE
Journal detail
Hereditary Cancer in Clinical Practice
- Publisher
- BioMed Central Ltd
- Country
- United Kingdom · Western Europe
- Type
- journal
- ISSN
-
1731230218974287
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,049
- Quartile Q2
- H-Index 36
- Cites/doc 2,75
- Docs (3y) 91
- Cites (3y) 247
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2,8
- 5Y JIF 2,3
- JCI 0,46
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Genetics (clinical) Q2
- Oncology Q2
Areas
- Medicine
WoS categories
- Oncology
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q3 | 1,049 | 2,8 | 2,3 | 0,46 | Q3 | 36 |
| 2024 | Q3 | Q3 | 0,648 | 2,4 | 2 | 0,36 | Q4 | 34 |
| 2023 | Q2 | Q3 | 0,729 | 2 | 1,9 | 0,38 | Q4 | 34 |
| 2022 | Q3 | Q4 | 0,526 | 1,7 | 2,2 | 0,35 | Q4 | 34 |
| 2021 | Q3 | Q4 | 0,546 | 2,2 | 2,1 | 0,41 | Q4 | 34 |
| 2020 | Q3 | Q4 | 0,857 | 2,9 | 2,6 | 0,5 | Q3 | 34 |
| 2019 | Q2 | Q4 | 0,839 | 2,2 | 2,2 | 0,46 | Q3 | 34 |
| 2018 | — | Q4 | — | 1,8 | 1,9 | 0,4 | Q4 | — |
| 2017 | Q2 | Q4 | 0,848 | 2 | 1,9 | 0,44 | Q3 | 34 |
| 2016 | Q3 | Q4 | 0,702 | 1,6 | 1,6 | — | — | 34 |
| 2015 | Q3 | Q4 | 0,655 | 1,6 | 1,7 | — | — | 34 |
| 2014 | Q3 | Q4 | 0,456 | 1,5 | 1,5 | — | — | 34 |
| 2013 | Q2 | Q3 | 0,718 | 2,1 | 1,8 | — | — | 34 |
| 2012 | Q3 | Q3 | 0,445 | 1,7 | 1 | — | — | 34 |
| 2011 | Q2 | Q3 | 0,759 | 1,7 | — | — | — | 34 |
| 2010 | Q3 | Q4 | 0,342 | 1 | — | — | — | 34 |
| 2009 | — | Q4 | — | 0,3 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | ONCOLOGY | SCIE | Q3 | Q3 | 179/333 |
| 2024 | ONCOLOGY | SCIE | Q3 | Q4 | 200/328 |
| 2023 | ONCOLOGY | SCIE | Q3 | Q4 | 222/322 |
| 2022 | ONCOLOGY | SCIE | Q4 | Q4 | 221/241 |
| 2021 | ONCOLOGY | SCIE | Q4 | Q4 | 218/245 |
| 2020 | ONCOLOGY | SCIE | Q4 | Q3 | 194/242 |
| 2019 | ONCOLOGY | SCIE | Q4 | Q3 | 187/244 |
| 2018 | ONCOLOGY | SCIE | Q4 | Q4 | 197/230 |
| 2017 | ONCOLOGY | SCIE | Q4 | Q3 | 173/223 |
| 2016 | ONCOLOGY | SCIE | Q4 | — | 181/217 |
| 2015 | ONCOLOGY | SCIE | Q4 | — | 178/213 |
| 2014 | ONCOLOGY | SCIE | Q4 | — | 176/211 |
| 2013 | ONCOLOGY | SCIE | Q3 | — | 131/203 |
| 2012 | ONCOLOGY | SCIE | Q3 | — | 145/197 |
| 2011 | ONCOLOGY | SCIE | Q3 | — | 138/196 |
| 2010 | ONCOLOGY | SCIE | Q4 | — | 159/185 |
| 2009 | ONCOLOGY | SCIE | Q4 | — | 158/166 |